梅斯健康(02415.HK)發盈喜，預計2023年度溢利不少於5,000萬人民幣，相較上年度錄得淨虧損。扭虧為盈主要受惠司業務規模擴大；集團內部加强對人工智能的應用，使生產效率提高；及可轉換可贖回優先股的公允價值收益。
《盈利預喜》梅斯健康(02415.HK)料去年轉賺不少於5,000萬人民幣
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.